Rockbridge Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$234K Hold
1,941
0.02% 133
2025
Q4
$204K Buy
+1,941
New +$182K 0.02% 134
2024
Q1
Sell
-1,492
Closed -$163K 434
2023
Q4
$163K Buy
+1,492
New +$155K 0.02% 136
2022
Q3
Sell
-1,665
Closed -$152K 408
2022
Q2
$152K Sell
1,665
-2,217
-57% -$197K 0.03% 119
2022
Q1
$324K Buy
3,882
+90
+2% +$7.1K 0.05% 116
2021
Q4
$291K Buy
3,792
+358
+10% +$28.5K 0.04% 140
2021
Q3
$258K Buy
3,434
+51
+2% +$3.88K 0.04% 124
2021
Q2
$263K Sell
3,383
-130
-4% -$9.67K 0.04% 127
2021
Q1
$258K Sell
3,513
-5,900
-63% -$435K 0.05% 120
2020
Q4
$735K Buy
9,413
+1
+0% +$76 0.15% 68
2020
Q3
$745K Buy
9,412
+1
+0% +$78 0.18% 59
2020
Q2
$694K Buy
+9,411
New +$708K 0.18% 62

Other funds holding MRK

Rockbridge Investment Management's MRK Position: Q1 2026 in Review

Rockbridge Investment Management held its Merck (MRK) position steady in Q1 2026 at 1,941 shares worth $234K. The position accounts for 0.02% of the portfolio, ranked #133.

Rockbridge Investment Management first reported a position in MRK in Q2 2020 and has held it in 12 quarters since. The position peaked at $745K in Q3 2020. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Rockbridge Investment Management held 1,941 shares of Merck worth $234K as of Q1 2026.
  • Rockbridge Investment Management left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.02% of Rockbridge Investment Management's portfolio in Q1 2026, its #133 holding.
  • Rockbridge Investment Management first reported a position in Merck in Q2 2020 and has held it in 12 quarters since.
  • Rockbridge Investment Management's Merck position peaked at $745K in Q3 2020.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Rockbridge Investment Management's 13F filing for Q1 2026, filed 14 May 2026.